Skip to main content
ASTAL LABORATORIES LIMITED logo

ASTAL LABORATORIES LIMITED — Investor Relations & Filings

Ticker · 512600 ISIN · INE307N01014 LEI · 8945004HO2WCBQ0CJ976 BSE.NS Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2021-07-07 Regulatory Filings
Country IN India
Listing BSE.NS 512600

About ASTAL LABORATORIES LIMITED

https://miel.co.in/

Astal Laboratories Limited is a pharmaceutical organization engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company's product portfolio encompasses various dosage forms, including tablets, capsules, liquid orals, and topical preparations. It operates across several therapeutic categories, such as anti-infectives, analgesics, and gastrointestinal treatments. Astal Laboratories prioritizes quality control and adheres to established manufacturing standards to ensure the safety and efficacy of its products. The company focuses on providing accessible healthcare solutions through a robust distribution network and a commitment to research-driven formulation development.

Recent filings

Filing Released Lang Actions
Compliances -Certificate under 74 (5) for the Quarter June 2021
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate issued by a SEBI-approved registrar and share transfer agent, confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. It relates to the dematerialization of securities for the quarter ended June 2021. The document is a regulatory compliance confirmation rather than a financial report or announcement of financial results. It is short (1827 characters) and does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance and regulatory confirmations that do not fit other specific categories.
2021-07-07 English
Closure of Trading window
Regulatory Filings Classification · 95% confidence The document is a formal notice from MACRO International Ltd. addressed to the Bombay Stock Exchange regarding the closure of the trading window under SEBI regulations. It specifies the period during which insiders are prohibited from trading due to the upcoming declaration of unaudited financial results for the quarter ended June 30, 2021. The document does not contain any financial data, results, or detailed reports but is an announcement related to compliance and trading restrictions ahead of financial disclosures. It is short (1441 characters) and serves as an intimation rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-07-01 English
Financial Result for the quarter and year ended 31 March 2021
Interim / Quarterly Report Classification · 95% confidence The document is a submission to the Bombay Stock Exchange dated June 30, 2021, containing audited financial results for the quarter and year ended March 31, 2021. It references Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, which pertains to financial results disclosures. The document includes detailed financial statements such as the statement of financial results, balance sheet, and notes, indicating it is a comprehensive financial report for a fiscal year. It also includes an auditor's report with an unmodified opinion. The length of the document (15,000 characters) and the presence of actual financial data confirm it is not merely an announcement but the full report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR) as it covers quarterly and annual audited financial results but is not a full Annual Report (10-K). Given the quarterly and year-end financial results are presented, the best classification is Interim / Quarterly Report (IR).
2021-06-30 English
Financial result for the Quarter and year ended on 31/03/2021
Interim / Quarterly Report Classification · 95% confidence The document is a submission to the Bombay Stock Exchange dated June 30, 2021, containing audited financial results for the quarter and year ended March 31, 2021. It references Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, which pertains to financial results disclosures. The document includes detailed financial statements such as the statement of financial results, balance sheet, and notes, indicating it is a comprehensive financial report rather than a brief announcement or certification. The presence of audited results and the auditor's report with an unmodified opinion further supports this classification. The document is not merely an announcement of results but contains substantive financial data and analysis for the full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR) as it covers quarterly and annual financial results but is not a full Annual Report (10-K). Given the detailed financial data and the quarterly/yearly period, the best classification is IR (Interim / Quarterly Report).
2021-06-30 English
Outcome of Board Meeting held on 30/06/2021
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the Bombay Stock Exchange regarding the outcome of a Board Meeting held on June 30, 2021. It references Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of financial results. The letter states that the Board considered, approved, and took on record the audited financial results for the quarter and year ended March 31, 2021, along with the auditor's report. It also mentions appointments of internal and secretarial auditors for the next financial year. The document is an announcement of the board meeting outcomes and financial results approval, not the full financial report itself. The document length is short (1786 characters), and it serves as an official announcement of the board meeting results and financial results approval, fitting the category of Regulatory Filings (RNS) rather than the full Annual Report (10-K) or Audit Report (AR).
2021-06-30 English
MACRO (INTERNATIONAL) EXPORTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve Intimation of ....
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to the Bombay Stock Exchange informing about an upcoming Board Meeting scheduled for June 30, 2021. The agenda includes approval of audited financial results and appointments of auditors. The document is an announcement of a board meeting rather than the meeting materials or minutes themselves. It does not contain financial data or detailed reports but serves as a notification in compliance with SEBI regulations. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is clearly an announcement, not the actual report or results.
2021-06-22 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.